{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:55:38Z","timestamp":1791492938535,"version":"4.3.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,21]],"date-time":"2021-03-21T00:00:00Z","timestamp":1616284800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,3,21]],"date-time":"2021-03-21T00:00:00Z","timestamp":1616284800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>As a secreted adipokine, adipsin has been recently shown to play a pivotal role in metabolic disorders. However, information regarding the association of circulating adipsin with non-alcoholic fatty liver disease (NAFLD) in humans is scant.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We recruited 1163 obese adult subjects with waist circumference at least 90\u00a0cm in men and 80\u00a0cm in women from the community. Circulating adipsin levels were measured by enzyme-linked immunosorbent assay.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Circulating adipsin levels of NAFLD subjects was decreased compared to those in non-NAFLD (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05). The prevalence of NAFLD with lower levels of serum adipsin was significantly higher than those with higher values (57.6% vs. 50.9%, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05). Circulating adipsin levels were significantly associated with decreasing levels of fasting glucose and postprandial glucose (both <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001 for interaction) in NAFLD subjects but not in non-NAFLD subjects. The risk of NAFLD was significantly decreased by 21.7% [OR (95% CI): 0.783 (0.679\u20130.902), <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001], adjusting for age, gender, current smoking, alcohol consumption, physical activity, BMI, systolic BP, fasting glucose, total cholesterol, HDL-c, HOMA-IR, and body fat mass. Importantly, subjects in the lowest quartile of circulating adipsin were 1.88 times more likely to have NAFLD than those in the highest quartile in multivariable logistic regression analyses. However, such associations with circulating adipsin were not noted for metabolic syndrome, abnormal liver enzyme and significant liver fibrosis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>These results demonstrate that circulating adipsin levels in Chinese obese adults are negatively associated with risk of NAFLD, implying that serum adipsin levels may be a potential protective factor in NAFLD.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12876-021-01721-9","type":"journal-article","created":{"date-parts":[[2021,3,21]],"date-time":"2021-03-21T04:51:39Z","timestamp":1616302299000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Association of circulating adipsin with nonalcoholic fatty liver disease in obese adults: a cross-sectional study"],"prefix":"10.1186","volume":"21","author":[{"given":"Jinhua","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangli","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peizhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingquan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youwen","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyun","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,21]]},"reference":[{"issue":"1","key":"1721_CR1","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73\u201384. https:\/\/doi.org\/10.1002\/hep.28431.","journal-title":"Hepatology"},{"issue":"4","key":"1721_CR2","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.jhep.2017.06.003","volume":"67","author":"JG Fan","year":"2017","unstructured":"Fan JG, Kim SU, Wong VW. New trends on obesity and NAFLD in Asia. J Hepatol. 2017;67(4):862\u201373. https:\/\/doi.org\/10.1016\/j.jhep.2017.06.003.","journal-title":"J Hepatol"},{"issue":"1","key":"1721_CR3","doi-asserted-by":"publisher","first-page":"62","DOI":"10.7860\/jcdr\/2014\/6691.3953","volume":"8","author":"R Patell","year":"2014","unstructured":"Patell R, Dosi R, Joshi H, Sheth S, Shah P, Jasdanwala S. Non-alcoholic fatty liver disease (NAFLD) in obesity. J Clin Diagn Res. 2014;8(1):62\u20136. https:\/\/doi.org\/10.7860\/jcdr\/2014\/6691.3953.","journal-title":"J Clin Diagn Res"},{"issue":"1 Suppl","key":"1721_CR4","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","volume":"62","author":"CD Byrne","year":"2015","unstructured":"Byrne CD, Targher G. NAFLD: a multisystem disease. J Hepatol. 2015;62(1 Suppl):S47-64. https:\/\/doi.org\/10.1016\/j.jhep.2014.12.012.","journal-title":"J Hepatol"},{"issue":"2","key":"1721_CR5","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.mce.2009.08.018","volume":"316","author":"S Galic","year":"2010","unstructured":"Galic S, Oakhill JS, Steinberg GR. Adipose tissue as an endocrine organ. Mol Cell Endocrinol. 2010;316(2):129\u201339. https:\/\/doi.org\/10.1016\/j.mce.2009.08.018.","journal-title":"Mol Cell Endocrinol"},{"issue":"4","key":"1721_CR6","doi-asserted-by":"publisher","first-page":"6184","DOI":"10.3390\/ijms15046184","volume":"15","author":"UJ Jung","year":"2014","unstructured":"Jung UJ, Choi MS. Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease. Int J Mol Sci. 2014;15(4):6184\u2013223. https:\/\/doi.org\/10.3390\/ijms15046184.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"1721_CR7","doi-asserted-by":"publisher","first-page":"854","DOI":"10.3390\/jcm8060854","volume":"8","author":"MW Lee","year":"2019","unstructured":"Lee MW, Lee M, Oh KJ. Adipose tissue-derived signatures for obesity and type 2 diabetes: adipokines, Batokines and MicroRNAs. J Clin Med. 2019;8(6):854. https:\/\/doi.org\/10.3390\/jcm8060854.","journal-title":"J Clin Med"},{"key":"1721_CR8","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.bcp.2019.03.030","volume":"165","author":"V Francisco","year":"2019","unstructured":"Francisco V, Ruiz-Fernandez C, Pino J, Mera A, Gonzalez-Gay MA, Gomez R, Lago F, Mobasheri A, Gualillo O. Adipokines: linking metabolic syndrome, the immune system, and arthritic diseases. Biochem Pharmacol. 2019;165:196\u2013206. https:\/\/doi.org\/10.1016\/j.bcp.2019.03.030.","journal-title":"Biochem Pharmacol"},{"issue":"9","key":"1721_CR9","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1161\/01.Res.0000163635.62927.34","volume":"96","author":"AH Berg","year":"2005","unstructured":"Berg AH, Scherer PE. Adipose tissue, inflammation, and cardiovascular disease. Circ Res. 2005;96(9):939\u201349. https:\/\/doi.org\/10.1161\/01.Res.0000163635.62927.34.","journal-title":"Circ Res"},{"issue":"9","key":"1721_CR10","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/nrendo.2017.56","volume":"13","author":"RCR Meex","year":"2017","unstructured":"Meex RCR, Watt MJ. Hepatokines: linking nonalcoholic fatty liver disease and insulin resistance. Nat Rev Endocrinol. 2017;13(9):509\u201320. https:\/\/doi.org\/10.1038\/nrendo.2017.56.","journal-title":"Nat Rev Endocrinol"},{"issue":"11","key":"1721_CR11","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1038\/s41591-019-0610-4","volume":"25","author":"N Gomez-Banoy","year":"2019","unstructured":"Gomez-Banoy N, Guseh JS, Li G, Rubio-Navarro A, Chen T, Poirier B, Putzel G, Rosselot C, Pabon MA, Camporez JP, Bhambhani V, Hwang SJ, Yao C, Perry RJ, Mukherjee S, Larson MG, Levy D, Dow LE, Shulman GI, Dephoure N, Garcia-Ocana A, Hao M, Spiegelman BM, Ho JE, Lo JC. Adipsin preserves beta cells in diabetic mice and associates with protection from type 2 diabetes in humans. Nat Med. 2019;25(11):1739\u201347. https:\/\/doi.org\/10.1038\/s41591-019-0610-4.","journal-title":"Nat Med"},{"issue":"1","key":"1721_CR12","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3109\/00365521.2010.516452","volume":"46","author":"Y Yilmaz","year":"2011","unstructured":"Yilmaz Y, Yonal O, Kurt R, Alahdab YO, Eren F, Ozdogan O, Celikel CA, Imeryuz N, Kalayci C, Avsar E. Serum levels of omentin, chemerin and adipsin in patients with biopsy-proven nonalcoholic fatty liver disease. Scand J Gastroenterol. 2011;46(1):91\u20137. https:\/\/doi.org\/10.3109\/00365521.2010.516452.","journal-title":"Scand J Gastroenterol"},{"issue":"6","key":"1721_CR13","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1111\/j.2047-6310.2012.00082.x","volume":"7","author":"E Fitzpatrick","year":"2012","unstructured":"Fitzpatrick E, Dew TK, Quaglia A, Sherwood RA, Mitry RR, Dhawan A. Analysis of adipokine concentrations in paediatric non-alcoholic fatty liver disease. Pediatr Obes. 2012;7(6):471\u20139. https:\/\/doi.org\/10.1111\/j.2047-6310.2012.00082.x.","journal-title":"Pediatr Obes"},{"issue":"1","key":"1721_CR14","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1159\/000495215","volume":"74","author":"Y Qiu","year":"2019","unstructured":"Qiu Y, Wang SF, Yu C, Chen Q, Jiang R, Pei L, Huang YL, Pang NZ, Zhang Z, Ling W, Yang L. Association of circulating adipsin, visfatin, and adiponectin with nonalcoholic fatty liver disease in adults: a case-control study. Ann Nutr Metab. 2019;74(1):44\u201352. https:\/\/doi.org\/10.1159\/000495215.","journal-title":"Ann Nutr Metab"},{"issue":"3","key":"1721_CR15","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.jhep.2013.04.030","volume":"59","author":"H-J Zhang","year":"2013","unstructured":"Zhang H-J, Zhang X-F, Ma Z-M, Pan L-L, Chen Z, Han H-W, Han C-K, Zhuang X-J, Lu Y, Li X-J, Yang S-Y, Li X-Y. Irisin is inversely associated with intrahepatic triglyceride contents in obese adults. J Hepatol. 2013;59(3):557\u201362. https:\/\/doi.org\/10.1016\/j.jhep.2013.04.030.","journal-title":"J Hepatol"},{"issue":"3","key":"1721_CR16","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1007\/s00125-007-0897-4","volume":"51","author":"G Targher","year":"2008","unstructured":"Targher G, Bertolini L, Rodella S, Zoppini G, Lippi G, Day C, Muggeo M. Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative\/laser-treated retinopathy in type 2 diabetic patients. Diabetologia. 2008;51(3):444\u201350. https:\/\/doi.org\/10.1007\/s00125-007-0897-4.","journal-title":"Diabetologia"},{"issue":"8","key":"1721_CR17","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1681\/ASN.2007101155","volume":"19","author":"G Targher","year":"2008","unstructured":"Targher G, Chonchol M, Bertolini L, Rodella S, Zenari L, Lippi G, Franchini M, Zoppini G, Muggeo M. Increased risk of CKD among type 2 diabetics with nonalcoholic fatty liver disease. J Am Soc Nephrol. 2008;19(8):1564\u201370. https:\/\/doi.org\/10.1681\/ASN.2007101155.","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"1721_CR18","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s12072-020-10094-2","volume":"14","author":"M Eslam","year":"2020","unstructured":"Eslam M, Sarin SK, Wong VW, Fan JG, Kawaguchi T, Ahn SH, Zheng MH, Shiha G, Yilmaz Y, Gani R, Alam S, Dan YY, Kao JH, Hamid S, Cua IH, Chan WK, Payawal D, Tan SS, Tanwandee T, Adams LA, Kumar M, Omata M, George J. The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease. Hepatol Int. 2020;14(6):889\u2013919. https:\/\/doi.org\/10.1007\/s12072-020-10094-2.","journal-title":"Hepatol Int"},{"key":"1721_CR19","doi-asserted-by":"publisher","unstructured":"EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J. Hepatol. 64(6), 1388\u20131402 (2016). https:\/\/doi.org\/https:\/\/doi.org\/10.1016\/j.jhep.2015.11.004","DOI":"10.1016\/j.jhep.2015.11.004"},{"key":"1721_CR20","doi-asserted-by":"publisher","DOI":"10.14744\/hf.2020.0006","author":"E Kaya","year":"2020","unstructured":"Kaya E, Bakir A, Eren F, Yilmaz Y. The utility of noninvasive scores in non-alcoholic fatty liver disease patients with normal and elevated serum transaminases. Hepatol Forum. 2020. https:\/\/doi.org\/10.14744\/hf.2020.0006.","journal-title":"Hepatol Forum"},{"issue":"4","key":"1721_CR21","doi-asserted-by":"publisher","first-page":"486","DOI":"10.5009\/gnl19173","volume":"14","author":"E Kaya","year":"2020","unstructured":"Kaya E, Bakir A, Kani HT, Demirtas CO, Keklikkiran C, Yilmaz Y. Simple noninvasive scores are clinically useful to exclude, not predict, advanced fibrosis: a study in Turkish patients with biopsy-proven nonalcoholic fatty liver disease. Gut and liver. 2020;14(4):486\u201391. https:\/\/doi.org\/10.5009\/gnl19173.","journal-title":"Gut and liver"},{"issue":"4","key":"1721_CR22","doi-asserted-by":"publisher","first-page":"584","DOI":"10.14309\/ajg.0000000000000572","volume":"115","author":"E Han","year":"2020","unstructured":"Han E, Lee YH, Kim YD, Kim BK, Park JY, Kim DY, Ahn SH, Lee BW, Kang ES, Cha BS, Han KH, Nam HS, Heo JH, Kim SU. Nonalcoholic fatty liver disease and sarcopenia are independently associated with cardiovascular risk. Am J Gastroenterol. 2020;115(4):584\u201395. https:\/\/doi.org\/10.14309\/ajg.0000000000000572.","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"1721_CR23","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12916-016-0703-6","volume":"14","author":"C Cai","year":"2016","unstructured":"Cai C, Lin M, Xu Y, Li X, Yang S, Zhang H. Association of circulating neuregulin 4 with metabolic syndrome in obese adults: a cross-sectional study. BMC Med. 2016;14(1):165. https:\/\/doi.org\/10.1186\/s12916-016-0703-6.","journal-title":"BMC Med"},{"issue":"9491","key":"1721_CR24","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/s0140-6736(05)67402-8","volume":"366","author":"KG Alberti","year":"2005","unstructured":"Alberti KG, Zimmet P, Shaw J. The metabolic syndrome\u2013a new worldwide definition. Lancet (Lond Engl). 2005;366(9491):1059\u201362. https:\/\/doi.org\/10.1016\/s0140-6736(05)67402-8.","journal-title":"Lancet (Lond Engl)"},{"issue":"1","key":"1721_CR25","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.cell.2014.06.005","volume":"158","author":"JC Lo","year":"2014","unstructured":"Lo JC, Ljubicic S, Leibiger B, Kern M, Leibiger IB, Moede T, Kelly ME, Chatterjee Bhowmick D, Murano I, Cohen P, Banks AS, Khandekar MJ, Dietrich A, Flier JS, Cinti S, Bluher M, Danial NN, Berggren PO, Spiegelman BM. Adipsin is an adipokine that improves beta cell function in diabetes. Cell. 2014;158(1):41\u201353. https:\/\/doi.org\/10.1016\/j.cell.2014.06.005.","journal-title":"Cell"},{"issue":"1","key":"1721_CR26","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.maturitas.2014.06.008","volume":"79","author":"P Chedraui","year":"2014","unstructured":"Chedraui P, Perez-Lopez FR, Escobar GS, Palla G, Montt-Guevara M, Cecchi E, Genazzani AR, Simoncini T. Circulating leptin, resistin, adiponectin, visfatin, adipsin and ghrelin levels and insulin resistance in postmenopausal women with and without the metabolic syndrome. Maturitas. 2014;79(1):86\u201390. https:\/\/doi.org\/10.1016\/j.maturitas.2014.06.008.","journal-title":"Maturitas"},{"issue":"11","key":"1721_CR27","doi-asserted-by":"publisher","first-page":"758","DOI":"10.7326\/0003-4819-159-11-201312030-00008","volume":"159","author":"CK Kramer","year":"2013","unstructured":"Kramer CK, Zinman B, Retnakaran R. Are metabolically healthy overweight and obesity benign conditions?: A systematic review and meta-analysis. Ann Intern Med. 2013;159(11):758\u201369. https:\/\/doi.org\/10.7326\/0003-4819-159-11-201312030-00008.","journal-title":"Ann Intern Med"},{"issue":"6","key":"1721_CR28","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1111\/cen.13157","volume":"85","author":"O Gursoy Calan","year":"2016","unstructured":"Gursoy Calan O, Calan M, Yesil Senses P, Unal Kocabas G, Ozden E, Sari KR, Kocar M, Imamoglu C, Senses YM, Bozkaya G, Bilgir O. Increased adipsin is associated with carotid intima media thickness and metabolic disturbances in polycystic ovary syndrome. Clin Endocrinol (Oxf). 2016;85(6):910\u20137. https:\/\/doi.org\/10.1111\/cen.13157.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"1721_CR29","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1007\/s10753-013-9620-4","volume":"36","author":"G Derosa","year":"2013","unstructured":"Derosa G, Fogari E, D\u2019Angelo A, Bianchi L, Bonaventura A, Romano D, Maffioli P. Adipocytokine levels in obese and non-obese subjects: an observational study. Inflammation. 2013;36(4):914\u201320. https:\/\/doi.org\/10.1007\/s10753-013-9620-4.","journal-title":"Inflammation"},{"issue":"2","key":"1721_CR30","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1210\/js.2018-00359","volume":"3","author":"JS Wang","year":"2019","unstructured":"Wang JS, Lee WJ, Lee IT, Lin SY, Lee WL, Liang KW, Sheu WH. Association between serum adipsin levels and insulin resistance in subjects with various degrees of glucose intolerance. J Endocr Soc. 2019;3(2):403\u201310. https:\/\/doi.org\/10.1210\/js.2018-00359.","journal-title":"J Endocr Soc"},{"issue":"1","key":"1721_CR31","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1590\/2359-3997000000147","volume":"60","author":"I Legakis","year":"2016","unstructured":"Legakis I, Mantzouridis T, Bouboulis G, Chrousos GP. Reciprocal changes of serum adispin and visfatin levels in patients with type 2 diabetes after an overnight fast. Arch Endocrinol Metab. 2016;60(1):76\u20138. https:\/\/doi.org\/10.1590\/2359-3997000000147.","journal-title":"Arch Endocrinol Metab"},{"issue":"11","key":"1721_CR32","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.3748\/wjg.v25.i11.1307","volume":"25","author":"JH Zhou","year":"2019","unstructured":"Zhou JH, Cai JJ, She ZG, Li HL. Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice. World J Gastroenterol. 2019;25(11):1307\u201326. https:\/\/doi.org\/10.3748\/wjg.v25.i11.1307.","journal-title":"World J Gastroenterol"},{"issue":"4","key":"1721_CR33","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1515\/jpem-2019-0463","volume":"33","author":"A Netaji","year":"2020","unstructured":"Netaji A, Jain V, Gupta AK, Kumar U, Jana M. Utility of MR proton density fat fraction and its correlation with ultrasonography and biochemical markers in nonalcoholic fatty liver disease in overweight adolescents. J Pediatr Endocrinol Metab. 2020;33(4):473\u20139. https:\/\/doi.org\/10.1515\/jpem-2019-0463.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"11","key":"1721_CR34","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1097\/MEG.0b013e3283623a16","volume":"25","author":"Y Yilmaz","year":"2013","unstructured":"Yilmaz Y, Ergelen R, Akin H, Imeryuz N. Noninvasive detection of hepatic steatosis in patients without ultrasonographic evidence of fatty liver using the controlled attenuation parameter evaluated with transient elastography. Eur J Gastroenterol Hepatol. 2013;25(11):1330\u20134. https:\/\/doi.org\/10.1097\/MEG.0b013e3283623a16.","journal-title":"Eur J Gastroenterol Hepatol"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-021-01721-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12876-021-01721-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-021-01721-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,21]],"date-time":"2021-03-21T04:52:58Z","timestamp":1616302378000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-021-01721-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,21]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1721"],"URL":"https:\/\/doi.org\/10.1186\/s12876-021-01721-9","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,21]]},"assertion":[{"value":"11 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Institutional Review Board of the First Affiliated Hospital of Xiamen University and Nanfang Hospital of Southern Medical University. The methods were carried out in accordance with the approved guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from each participant.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"No potential competing of interest were disclosed.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing of interest"}}],"article-number":"131"}}